about
Microcapsules prepared with different biomaterials to immobilize GDNF secreting 3T3 fibroblastsCell encapsulation: technical and clinical advances.Microcapsules and microcarriers for in situ cell delivery.Pharmacokinetics and tissue distribution of intravenous pefloxacin for antibiotic prophylaxis in biliary surgery.Encapsulated cell technology: from research to market.Bioactive cell-hydrogel microcapsules for cell-based drug delivery.An overview on the field of micro- and nanotechnologies for synthetic Peptide-based vaccinesDrug delivery in biotechnology: present and future.The search for new beta-cell sources.Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research.Novel advances in the design of three-dimensional bio-scaffolds to control cell fate: translation from 2D to 3D.Recent advances in the use of encapsulated cells for effective delivery of therapeutics.Therapeutic cell encapsulation: ten steps towards clinical translation.Application of cell encapsulation for controlled delivery of biological therapeutics.Nanotherapeutic approaches for brain cancer management.Advances in cell encapsulation technology and its application in drug delivery.Advances in drug delivery systems (DDSs) to release growth factors for wound healing and skin regeneration.Alginate Microcapsules Incorporating Hyaluronic Acid Recreate Closer in Vivo Environment for Mesenchymal Stem Cells.Characterization of an encapsulated insulin secreting human pancreatic beta cell line in a modular microfluidic device.Morphological Changes in a Severe Model of Parkinson's Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors.Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.Graphene oxide increases the viability of C2C12 myoblasts microencapsulated in alginate.Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration.Topographical Distribution of Morphological Changes in a Partial Model of Parkinson's Disease--Effects of Nanoencapsulated Neurotrophic Factors Administration.Optoacoustic imaging enabled biodistribution study of cationic polymeric biodegradable nanoparticles.Development of surface modified biodegradable polymeric nanoparticles to deliver GSE24.2 peptide to cells: a promising approach for the treatment of defective telomerase disorders.Multifunctional hydrogel-based scaffold for improving the functionality of encapsulated therapeutic cells and reducing inflammatory response.Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease.A novel strategy for the treatment of chronic wounds based on the topical administration of rhEGF-loaded lipid nanoparticles: In vitro bioactivity and in vivo effectiveness in healing-impaired db/db mice.Cryopreservation of microencapsulated murine mesenchymal stem cells genetically engineered to secrete erythropoietin.The synergistic effects of the RGD density and the microenvironment on the behavior of encapsulated cells: in vitro and in vivo direct comparative study.Encapsulation of cells in alginate gels.In vivo administration of VEGF- and GDNF-releasing biodegradable polymeric microspheres in a severe lesion model of Parkinson's disease.Encapsulated VEGF-secreting cells enhance proliferation of neuronal progenitors in the hippocampus of AβPP/Ps1 mice.VEGF-releasing biodegradable nanospheres administered by craniotomy: a novel therapeutic approach in the APP/Ps1 mouse model of Alzheimer's disease.Optimization of 100 μm alginate-poly-L-lysine-alginate capsules for intravitreous administration.LL37 loaded nanostructured lipid carriers (NLC): A new strategy for the topical treatment of chronic wounds.Cryopreservation based on freezing protocols for the long-term storage of microencapsulated myoblasts.Biocompatibility and in vivo evaluation of oligochitosans as cationic modifiers of alginate/Ca microcapsules.In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules.
P50
Q28240684-6AF38D31-78EF-46FA-B94F-03CF498956C2Q34044198-AFB7FA88-20F6-49FF-AE82-2A4942723845Q34098543-44C0092C-FE94-4B77-8CBE-2A849C7A6B7BQ34527809-128D17AD-86F9-485C-8619-A4343E19BEB2Q34783715-F4269CC3-8807-4BEB-8CEA-36A720CBDC76Q34974084-5BC5B4BB-25E2-4285-AD7C-3FF4D5DE1D66Q35100779-A183B79A-2CB9-4400-98A6-C82CBCA1A22EQ35603069-C4D2C4B3-BB57-4D07-A072-A7B929512D00Q35948213-904850C1-C73A-4F2E-A3DF-89B322706313Q37981001-5661E61B-A528-4593-BDF7-31832838A168Q38007747-EF131BB6-94C5-4C39-B75E-E53767441CD8Q38027856-49C6844A-AEFA-408F-9F80-ACE6BFE23E1EQ38104179-BC908369-627C-47EC-94E4-89C7078D95DAQ38124171-ACD101A5-B0C1-42E8-8D9D-291E4BEDE109Q38153559-0543A89B-2936-4D6C-8649-7D137AB9357CQ38308868-0D977E78-66A7-4949-8E8A-63083AA7C71BQ38389266-CF8E4E0C-8B5A-4280-AA2E-7B31B23A9FCDQ38677184-C450F0CE-B038-4EE3-8037-50213070C5BFQ38702564-20906116-6A7F-4656-8E1E-4DE3981E3E9DQ38731068-B590454A-B205-4D7F-9E5C-40B241101FEAQ38808008-351764E0-4AC9-4A19-A8F5-A118385129E8Q38848406-4401A3F1-F9D4-4FC9-B24A-3718FB998D0BQ38849417-071ACD52-C1FA-49FD-A666-3F56CAC6B7F2Q38867773-F5840F29-5811-459A-9BF5-054714AD46A7Q38870192-FC549E1C-C14B-42FF-9933-057E993E5DCDQ38911986-6E5A960F-51FF-4A04-8A59-83F343BB666FQ38976711-DAA383AD-9111-42EC-A97F-0ECA31E105ABQ38985632-61714D3B-4813-4B8D-8164-130F7D4A95B4Q38998686-E3C87FB9-7070-4F54-A323-4138FC388600Q39036169-90D3A19A-4B76-4987-80DB-0FDEB961697FQ39038615-CB288BF9-43A5-4C77-A926-3A83304E7BF7Q39112069-C7BFFA6A-D94D-4524-9C93-9C51D978E4C6Q39156949-26B083E7-AFBE-40D6-B40B-96BFBD3F7999Q39414656-5F701681-514C-422D-BFDD-842F4ADEC91AQ39416841-4CA60BE9-F545-4E59-BDE6-5DD94CDF3463Q39463355-0EF21748-141D-4F24-8D1A-FF7A17A30EE6Q39849807-A218515A-8E35-4705-A436-EF054BBFB8B1Q39867356-4991C355-16FC-427D-8FBA-34951D960E62Q39895067-95F63BDD-4103-4C3E-AF4C-7E4F849C3C38Q40212781-66D7BBEA-470E-4728-8230-083459CDE9DD
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rosa Maria Hernandez
@ast
Rosa Maria Hernandez
@en
Rosa Maria Hernandez
@es
Rosa Maria Hernandez
@nl
Rosa Maria Hernandez
@sl
type
label
Rosa Maria Hernandez
@ast
Rosa Maria Hernandez
@en
Rosa Maria Hernandez
@es
Rosa Maria Hernandez
@nl
Rosa Maria Hernandez
@sl
prefLabel
Rosa Maria Hernandez
@ast
Rosa Maria Hernandez
@en
Rosa Maria Hernandez
@es
Rosa Maria Hernandez
@nl
Rosa Maria Hernandez
@sl
P1053
S-6332-2017
P106
P1153
35586067900
P21
P31
P4012
P496
0000-0002-3947-409X